The role of oxidative stress and antioxidants in the pathogenesis of age-related macular degeneration

Clinics

Volumn 66, Issue 5, 2011, Pages 743-746

  Yildirim, Zuhal ^a   Ucgun, Nil Irem ^b   Yildirim, Filiz ^c  

^a Etimesgut Public Health Laboratory   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c Duatepe Government Hospital   (Turkey)

Author keywords

AMD; Antioxidants; Oxidative stress; Protein oxidation

Indexed keywords

BIOLOGICAL MARKER; GLUTATHIONE PEROXIDASE; SUPEROXIDE DISMUTASE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; ENZYMOLOGY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; METABOLISM; MIDDLE AGED; OXIDATIVE STRESS; PHYSIOLOGY; RETINA MACULA DEGENERATION; SUBRETINAL NEOVASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOROIDAL NEOVASCULARIZATION; FEMALE; GLUTATHIONE PEROXIDASE; HUMANS; LIPID PEROXIDATION; MACULAR DEGENERATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 79960748368     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322011000500006     Document Type: Article

References (44)

1. Seddon JM, George S, Rosner B, Rifai N. Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6 and, and other cardiovascular biomarkers. Arch Ophthalmol. 2005;123:774-82 doi: 10.1001/archopht.123.6.774.
2. Drobek-Slowik M, Karczewicz D, Safranow K. The potential role of oxidative stress in the pathogenesis of the age-related macular degeneration (AMD). Postepy Hig Med Dosw. 2007;61:28-37.
3. Ding X, Patel M, Chan CC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2009;28:1-18doi: 10.1016/j.preteyeres. 2008.10.001.
4. Tsai YY, Lin JM, Wan L, Lin HJ, Tsai Y, Lee CC, et al. Interleukin gene polymorphisms in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2008;49:693-8 doi: 10.1167/iovs.07-0125.
5. Smith W, Assink J, Klein R, Mitchell P, Klacer CC, Klein BE, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology. 2001;108:697-704 doi: 10.1016/S0161- 6420(00)00580-7.
6. Seddon JM, Cote J, Rosner B. Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Arch Ophthalmol. 2003;121:1728-37 doi: 10.1001/ archopht.121.12.1728.
7. Seddon JM, Rosner B, Sperduto RD, Yannuzzi L, Haller JA, Blair NP, et al. Dietary fat and risk for advanced age-related macular degeneration. Arch Ophthalmol. 2001;119:1191-9.
8. Cho E, Hung S, Willett W, Spiegelman D, Rimm EB, Seddon JM, et al. Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr. 2001;73:209-8.
9. Seddon JM, Cote J, Davis N, Rosner B. Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol. 2003;21:785-92 doi: 10.1001/archopht.121.6.785.
10. Seddon JM, Ajani UA, Sperduto RD, Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye disease Case-Control Study Group. JAMA. 1994;272:1413-20 doi: 10.1001/jama. 272.18.1413.
11. Ohia SE, Opere CA, Leday AM. Pharmacological consequences of oxidative stress in ocular tissues. Mutat Res. 2005;579:22-36.
12. Halliwell B, Gutteridge J. Free radicals in biology and medicine. 3rd ed. New York:Oxford University Press Inc, 1989:1-35.
13. Irmak MK, Fadillioglu E, Sogut S, Erdogan H, Gulec M, Ozer M, et al. Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfu- sion injury in rat brain. Cell Biochem Funct. 2003;21:283-9 doi: 10.1002/ cbf.1024.
14. Touyz RM. Reactive oxygen species and angiotensin II signaling in vascular cells-implications in cardiovascular disease. Braz J Med Biol Res. 2004;37:1263-73 doi: 10.1590/S0100-879X2004000800018.
15. Olivares-Corichi IM, Ceballos G, Ortega-Camarillo C, Guzman-Grenfell AM, Hicks JJ. Reactive oxygen species (ROS) induce chemical and structural changes on human insulin in vitro, including alterations in its immunoreactivity. Front Biosci. 2005;10:834-43.
16. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304-13 doi: 10.1038/ki.1996.186.
17. Harman D. Free radical theory of aging: An update: Increasing the functional life span. Ann N Y Acad Sci. 2006;1067:10-21 doi: 10.1196/annals.1354.003.
18. Fairfield KM, Fletcher RH. Vitamins for chronic disease prevention in adults: scientific review. JAMA. 2002;287:3116-26 doi: 10.1001/jama.287. 23.3116.
19. Pryor WA, Godber SS. Noninvasive measures of oxidative stress status in humans. Free Radic Biol Med. 1991;10:177-84 doi: 10.1016/0891-5849(91)90073-C.
20. Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated- oxygen toxicity in the blood. Am J Obstet Gynecol. 1979;135:372-6.
21. Kurtel H, Granger DN, Tso P, Grisham MB. Vulnerability of intestinal interstitial fluid to oxidant stress. Am J Physiol. 1992;263:G573-G578.
22. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem. 1988;34:497-500.
23. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erytrocyte glutathione peroxidase. J Lab Clin Med. 1967;70:158-69.
24. Mapson LW. The estimation of dehydro-L-ascorbic acid when present in low concentration in tissues, by the Roe and Kuether procedure. Ann N Y Acad Sci. 1961; 92:284-5doi: 10.1111/j.1749-6632.1961.tb46127.x.
25. Cai J, Nelson KC, Wu M, Sternberg PJr, Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19:205-21 doi: 10.1016/ S1350-9462(99)00009-9.
26. Harris A, Chung HS, Ciulla TA, Kagemann L. Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog Retin Eye Res. 1999;18:669-87doi: 10.1016/S1350-9462(98)00037-8.
27. Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH. A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res. 2000;70:441-9doi: 10.1006/exer.1999.0798.
28. Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J. 2000;14:835-46.
29. Johnson LV, Leitner WP, Staples MK, Anderson DH. Complement activation and inflammatory processes in drusen formation and age related macular degeneration. Exp Eye Res. 2001;73:887-96doi: 10.1006/ exer.2001.1094.
30. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Brunch's mem- brane interface in aging and age-related macular degeneration. Prog Retin Eye Res. 2001;20:705-32doi: 10.1016/S1350-9462(01)00010-6.
31. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role of for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol. 2002;134:411-31 doi: 10.1016/S0002-9394(02)01624-0.
32. Liang FQ, Godley BF. Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism RPE aging and age-related macular degeneration. Exp Eye Res. 2003;76:397-403 doi: 10.1016/S0014-4835(03)00023-X.
33. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-34 doi: 10.1016/S0039-6257(00)00140-5.
34. Ito T, Nakano M, Yamamoto Y, Hiramitsu T, Mizuno Y. Hemoglobin- induced lipid peroxidation in the retina: a possible mechanism for macular degeneration. Arch Biochem Biophys. 1995;316:864-72 doi: 10. 1006/abbi.1995.1116.
35. De La Paz MA, Anderson RE. Lipid peroxidation in rod outer segments. Role of hydroxyl radical and lipid hydroperoxides. Invest Ophthalmol Vis Sci. 1992;33:2091-6.
36. Totan Y, Çekiç O, Borazan M, Uz E, Sog ̌ut S, Akyol O. Plasma malondialdehyde and nitric oxide levels in age related macular degeneration. Br J Ophthalmol. 2001;85:1426-8 doi: 10.1136/bjo.85.12. 1426.
37. Evereklioglu C, Er H, Doganay S, Cekmen M, Turkoz Y, Otlu B, Ozerol E. Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration. Doc Ophthalmol. 2003;106:129-36 doi: 10.1023/ A:1022512402811.
38. Totan Y, Yag ̌ci R, Bardak Y, Ozyurt H, Kendir F, Yİlmaz G, Sahin S, Sahin Ti{dotless}g ̌ U. Oxidative macromolecular damage in age-related macular degeneration. Curr Eye Res. 2009;34:1089-93 doi: 10.3109/ 02713680903353772.
39. Alderman CJ, Shah S, Foreman JC, Chain BM, Katz DR. The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic Bio Med. 2002;32:377-85 doi: 10.1016/S0891- 5849(01)00735-3.
40. Beatty S, Koh H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115-34 doi: 10.1016/S0039-6257(00)00140-5.
41. Enghild JJ, Thogersen IB, Oury TD, Valnickova Z, Hojrup P, Crapo JD. The heparin-binding domain of extracellular superoxide dismutase is proteolytically processed intracellularly during biosynthesis. J Biol Chem. 1999;274:14818-22 doi: 10.1074/jbc.274.21.14818.
42. Penninckx M. A short review on the role of glutathione in the response of yeasts to nutritional, environmental, and oxidative stresses. Enzyme Microb Technol. 2000;26:737-42 doi: 10.1016/S0141-0229(00)00165-4.
43. Samiec PS, Drews-Botsch C, Flagg EW, Kurtz JC, Sternberg PJr, Reed RL, Johns DP. Glutathione in human plasma decline: in association with aging, age-related macular degeneration, and diabetes. Free Radic Biol Med. 1998;24:699-704 doi: 10.1016/S0891-5849(97)00286-4.
44. Antioxidant status and neovascular age-related macular degeneration. Eye Disease Case-Control Study Group. ch Ophthalmol. 1993;111:104-9 Erratum in: Arch Ophthalmol 1993 Sep;111(9):1228, 1993 Oct;111(10):1366. Arch Ophthalmol 1993 Nov;111(11):1499.